Reaction with Fructose Detoxifies Fumonisin B1 while Stimulating Liver-Associated Natural Killer Cell Activity in Rats by Lu, Z. et al.
Food Science and Human Nutrition Publications Food Science and Human Nutrition
3-17-1997
Reaction with Fructose Detoxifies Fumonisin B1
while Stimulating Liver-Associated Natural Killer
Cell Activity in Rats
Z. Lu
Iowa State University
W. R. Dantzer
Iowa State University
E. C. Hopmans
Iowa State University
V. Prisk
Iowa State University
Joan E. Cunnick
Iowa State University, jcunnick@iastate.edu
See next page for additional authors
Follow this and additional works at: http://lib.dr.iastate.edu/fshn_ag_pubs
Part of the Animal Sciences Commons, Food Science Commons, Human and Clinical Nutrition
Commons, Other Microbiology Commons, and the Other Veterinary Medicine Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
fshn_ag_pubs/88. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Food Science and Human Nutrition at Digital Repository @ Iowa State University. It has
been accepted for inclusion in Food Science and Human Nutrition Publications by an authorized administrator of Digital Repository @ Iowa State
University. For more information, please contact digirep@iastate.edu.
Authors
Z. Lu, W. R. Dantzer, E. C. Hopmans, V. Prisk, Joan E. Cunnick, Patricia A. Murphy, and Suzanne Hendrich
This article is available at Digital Repository @ Iowa State University: http://lib.dr.iastate.edu/fshn_ag_pubs/88
Reaction with Fructose Detoxifies Fumonisin B1 while Stimulating
Liver-Associated Natural Killer Cell Activity in Rats
Z. Lu,† W. R. Dantzer,† E. C. Hopmans,† V. Prisk,† J. E. Cunnick,‡ P. A. Murphy,† and
S. Hendrich*,†
Department of Food Science and Human Nutrition and Department of Microbiology, Immunology and
Preventive Medicine, Iowa State University, Ames, Iowa 50011
Fumonisin B1 (FB1) was reacted with fructose in an attempt to detoxify this mycotoxin. Fischer
344/N rats were initiated with diethylnitrosamine (15 mg/kg body weight) and then fed 69.3 ímol
FB1/kg diet or 69.3 ímol FB1 reacted with fructose (FB1-fructose)/kg diet for 4 weeks. In comparison
with the rats fed basal diet or FB1-fructose, the FB1-fed rats had significantly increased plasma
cholesterol (P < 0.01), plasma alanine aminotransferase activity (P < 0.05), and endogenous hepatic
prostaglandin production (P < 0.05). Placental glutathione S-transferase-positive and ç-glutamyl
transferase-positive altered hepatic foci occurred only in the FB1-fed rats. Liver-associated natural
killer (NK) cell activity was significantly decreased in the FB1-fed rats and increased in the group
fed FB1-fructose, as compared with the basal group (P < 0.03). Therefore, modifying FB1 with
fructose seems to prevent FB1-induced hepatotoxicity and promotion of hepatocarcinogenesis while
stimulating liver-associated NK cell activity in rats.
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INTRODUCTION
Fumonisin B1 (FB1), a mycotoxin produced by the
commonly occurring corn fungi, Fusarium moniliforme
and Fusarium proliferatum, was hepatocarcinogenic in
rats when fed in amounts of 69.3 ímol/kg diet (50 ppm)
for approximately 2 years (Gelderblom et al., 1991).
Human esophageal cancer rate was high in areas where
FB1 concentration in corn reached approximately 11.1
ímol/kg (Sydenham et al., 1990a). Corn products for
human and animal consumption were determined to
contain 0.3-4.2 ímol FB1/kg (Hopmans and Murphy,
1993; Murphy et al., 1993; Sydenham et al., 1990b).
The hepatocarcinogenic effect of FB1 can be evaluated
in vivo by measuring changes in placental glutathione
S-transferase (PGST) (Lebepe-Mazur et al., 1995) and
ç-glutamyl transferase (GGT) activity (Gelderblom et
al., 1988), which are markers of altered hepatic foci
(AHF) (Sato et al., 1984; Goldsworthy et al., 1985). Also,
plasma alanine aminotransferase (ALT) activity was
related to fumonisin hepatotoxicity (Voss et al., 1992)
and hepatocarcinogenesis in rats (Hendrich et al., 1993).
Increased plasma total cholesterol was also an indicator
of FB1 toxicity in vervet monkeys (Fincham et al., 1992)
and in rats (Hendrich et al., 1993). Production of
prostaglandin E2 (PGE2) and other eicosanoids from the
cyclooxygenase pathway was stimulated in Yoshida
hepatoma cells in rats and in human hepatocellular
carcinomas (Trevisani et al., 1980; Hanai et al., 1993).
Effects of FB1 on PG production in rat liver have not
been investigated yet.
Fumonisin B1 can alter immunological functions
mediating antitumor mechanisms. Macrophage struc-
ture and phagocytic function were down-regulated in
vitro by FB1 (Chatterjee and Mukherjee, 1994; Chat-
terjee et al., 1995) as was lymphocyte proliferation in
response to lipopolysaccharides (LPS) (Dombrink-
Kurtzman et al., 1994). The effects of in vivo admin-
istration of FB1 produced both increases and decreases
in plaque-forming cell response in BALB/C mice de-
pending upon the timing of the fumonisin injections and
the number of injections (Martinova and Merrill, 1995).
Efforts have been devoted to detoxifying FB1 in
several ways. Thermostability of FB1 proved to be
great, because nearly 85% of FB1 was recovered after
different heat treatments: 75 °C for 135 min, 100 °C
for 45 min, and 125 °C for 5 min (Dupuy et al., 1993).
Treatment of fumonisin-contaminated corn with 2%
ammonia for 4 days, a process that detoxified aflatoxin
B1, led to slight reduction in the concentration of FB1
without decreasing the toxicity in rats (Norred et al.,
1991). Hydrolyzed FB1, which was produced by boiling
F. proliferatum-contaminated corn in 1.2% calcium
hydroxide solution for 1 h, was similar in toxicity to FB1
when the nutritional status of rats was adequate
(Hendrich et al., 1993). In vitro toxicity studies on
several analogs of FB1 showed that the analogs contain-
ing FB1’s amine group and the tricarballylic side chains
were more toxic than FB1, whereas the analog contain-
ing only the tricarballylic side chains was not toxic
(Kraus et al., 1992). The N-acetyl derivative of FB1 at
1 mM was less toxic in primary rat hepatocytes than
FB1 at the same concentration. In addition, rats fed
N-acetyl-FB1 at about 1.3 mmol/kg diet did not exhibit
hepatic neoplastic nodules or increased hepatic GGT
activity (Gelderblom et al., 1993). Therefore, FB1’s
amine group is likely to be critical for its toxicity. The
N-acetyl-FB1 may be produced during the isolation and
purification of FB1 from corn cultures of F. moniliforme.
This paper describes a dedicated and more practical
method to block FB1’s amine group by reacting the
amine group with reducing sugars such as fructose in
a Maillard reaction. It was hypothesized that modifying
FB1 with fructose would reduce or prevent promotion
of hepatocarcinogenesis and hepatotoxicity in rats.
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MATERIALS AND METHODS
Preparation of Crude Fumonisin B1. Fumonisin B1 is
a class 2B carcinogen (International Agency for Research on
Cancer, 1993), and standard safety precautions were taken
during its handling.
F. proliferatum strain M5991 (from Dr. Paul Nelson,
Pennsylvania State University, College Station, PA) predomi-
nantly produces FB1. Sterile, aflatoxin-free corn was inocu-
lated with lyophilized cultures of F. proliferatum strain M5991
which had been reconstituted in pH 7.4 phosphate-buffered
saline. This corn culture was incubated at 22 °C in the dark
for 3 weeks. After incubation, freeze-dried corn culture was
ground and extracted with 1:1 acetonitrile:water. The extract
was partitioned with ethyl acetate, after which the water phase
was loaded onto a 1 kg XAD-16 column (7.5  100 cm, Sigma
Chemical Co., St. Louis, MO). The column was washed with
water, and FB1 was eluted with 4 L of methanol. The eluate
was dried under vacuum, reconstituted in water, and loaded
onto a Lobar LiChroprep RP-8 column (25  310 mm; EM
Separations, Gibbstown, NJ). The column was washed with
20% acetonitrile:80% water containing 0.1% trifluoroacetic acid
(TFA), and FB1 was eluted with 50% acetonitrile:50% water
containing 0.1% TFA. The purity of the isolated FB1 was
determined by analytical HPLC of the o-phthaldialdehyde
(OPA) derivative (Hopmans and Murphy, 1993). The FB1
standard curve was prepared with FB1 generously donated by
Dr. P. G. Thiel (Research Institute for Nutritional Diseases,
South African Medical Research Council, South Africa). The
isolated FB1 was approximately 40% pure, containing 1.5 g of
FB1. The preparation also contained trace amounts of fumo-
nisins B2 and B3.
Preparation of Highly Purified Fumonisin B1. Liquid
cultures were prepared as in Dantzer et al. (1996a) by
inoculating capped baffled Erlenmeyer flasks containing 500
mL of modified Myro medium with a 4 day shake flask culture
of F. proliferatum strain M5991. Fumonisin B1 was isolated
and purified by the procedure as described in Dantzer et al.
(1996b). Briefly, harvested liquid cultures were filtered and
run over a series of chromatographic steps, including Amber-
lite XAD-16, reverse phase Lobar C8, ion exchange DEAE
Sepharose, and reverse phase YMC C18, until FB1 purity >95%
was obtained. Purified FB1 solutions were freeze-dried, and
a dry weight was determined. The purified FB1 was dissolved
volumetrically and assayed for FB1 as described by Hopmans
and Murphy (1993). The mass of FB1 was calculated from the
standard curve and compared with the weighed mass of freeze-
dried FB1. This ratio was taken as the percent purity of FB1
(Dantzer et al., 1996b). The purity of the FB1 was confirmed
to be >95% by Dr. Ronald Plattner (USDA-ARS, National
Center for Utilization Research, Peoria, IL).
Preparation of Fumonisin B1-Fructose Adduct. Both
crude and highly purified FB1 were conjugated with fructose
as described by Murphy et al. (1995). Briefly, 725 íM FB1 in
50 mM potassium phosphate buffer, pH 7.0, containing 1 M
fructose, was heated for 48 h at 80 °C. Less than 5% of the
FB1 was left unreacted with fructose. Fumonisin B1-fructose
was hydrolyzed by refluxing in 2 N KOH for 2 h at 100 °C,
after which the pH was adjusted to 2.8 with 2 N HCl. All of
the FB1 could be recovered as hydrolyzed FB1. In addition,
FB1 was heated under the same conditions without fructose
and retained 100% reactivity with OPA.
Diets. Three experimental diets were fed to rats in each
of the two studies. Basal diet supplying 40% of energy as fat
was modified from AIN-76 (American Institute of Nutrition,
1977) in the study feeding crude FB1, or from AIN-93G
(American Institute of Nutrition, 1993) in the study feeding
highly purified FB1 (Table 1). Crude or highly purified FB1-
containing diets were prepared by incorporating 69.3 ímol FB1/
kg diet into the basal diets. Crude or highly purified FB1
reacted with fructose were incorporated into the basal diets
at a level equivalent to 69.3 ímol FB1/kg diet. On the basis
of the proposed reaction between FB1 and a reducing sugar
such as fructose (Murphy et al., 1996), it was estimated that
approximately 17 g of unreacted fructose was added per
kilogram of FB1-fructose diet. All the diets were stored at 4
°C.
Animals. The use of animals and the experimental proce-
dures were approved by the Iowa State University Animal
Care Committee. In the experiment with crude FB1, 20 10-
day-old male F344/N rats obtained from Harlan Sprague-
Dawley (Madison, WI) were injected intraperitoneally with
diethylnitrosamine (DEN, 15 mg/kg body weight) in 0.1 mL
of corn oil. At 3 weeks of age, the weaned rats were randomly
assigned into one of the three treatment groups with six or
seven rats each. In the experiment with highly purified FB1,
39 10-day-old female F344/N rats obtained from Harlan
Sprague-Dawley were initiated as described above, randomly
assigned into the treatments with 12-15 rats each. In both
experiments, rats were given free access to the experimental
diets and water for 4 weeks in an animal facility with a 12-h
light/dark cycle maintained at 22-25 °C and 50% humidity.
Body weight and feed intake of the female rats were recorded
weekly.
Plasma and Liver Sample Preparations. Part of the
plasma obtained from heparinized blood was analyzed within
24 h for ALT activity. The remaining plasma was stored at
-80 °C and later analyzed for plasma total cholesterol.
The liver was perfused with 40 mL of Hank’s balanced salt
solution containing 1% EDTA and 25 mM HEPES. The
perfusate (10-12 mL) containing red blood cells, Pitt cells, and
other leukocytes was used as the source of effectors in the NK
cell activity assay.
Each of the three largest lobes of the liver was sliced into 1
cm slices. Three slices, one from each lobe, were immediately
frozen as a block on dry ice and stored at -80 °C. From each
of the frozen liver blocks, two 10-ím serial sections were cut
with a Histostat Microtome (Model 855, Leica Inc., Deerfield,
IL) for later stainings for GGT activity and PGST.
From each rat, 0.5 g of minced liver portions was im-
mediately homogenized in an ice bath with 10 passes of a
Table 1. Basal Diet Compositiona
ingredient
crude FB1
expt (g/kg)
purified FB1
expt (g/kg)
beef tallow 139.6 139.6
corn oil 66.5
soybean oil 66.5
casein 224.1 224.1
corn starch 228.5 228.5
dextrose 224.1 224.1
cellulose 56.0 56.0
vitamin mix (AIN-76) 11.2
vitamin mix (AIN-93G-VX) 10.0
mineral mix (AIN-76) 39.2
mineral mix (AIN-93G-MX) 39.2
CaCO3 5.0
choline chloride 2.2
L-methionine 3.4
ascorbate 0.1
L-cystine 3.0
choline bitartrate 2.5
TBHQ 0.014
a Basal diet modified from AIN-76 was used in crude FB1
experiment; basal diet modified from AIN-93G was used in highly
purified FB1 experiment.
Table 2. Differences in Body Weight but Not Feed Intake
among Female Rats Fed Fumonisin B1 (FB1), FB1
Reacted with Fructose (FB1-Fructose), or a Basal Diet
group
basal FB1-fructose FB1
total feed intake (g) 366 ( 37 354 ( 43 320 ( 25
average daily feed
intake (g/d)
13 ( 1 13 ( 2 11 ( 1
final body weight (g) 191 ( 19 191 ( 10 171 ( 14a
body weight increase (g) 128 ( 15 128 ( 8 108 ( 15a
a Significantly different from the basal group, P < 0.05.
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Potter-Elvenhjem homogenizer in 5 mL, pH 7.4, 50 mM
potassium phosphate buffer containing 4.2 mM acetylsalicylic
acid. The liver homogenates were frozen on dry ice and stored
at -80 °C for later analyses of endogenous hepatic PGF2R and
PGE2 levels.
Plasma Total Cholesterol Concentration and Alanine
Aminotransferase Activity. Plasma total cholesterol con-
centration was determined by using Sigma diagnostic kit,
procedure 352-3 (Sigma). Plasma ALT activity was measured
by using Sigma diagnostic kit for glutamate/pyruvate trans-
aminase optimized ALT assay (Sigma).
Histochemical Staining and Computerized Stereology
of AHF. One of the frozen serial sections was stained for the
presence of PGST-positive altered hepatic foci (AHF). Pla-
cental glutathione S-transferase was detected by the peroxi-
dase-anti-peroxidase (PAP) method using a Vectastain ABC
avidin-biotin universal rabbit PAP kit (Vector Laboratories,
Burlingame, CA). Placental glutathione S-transferase was
purified by the method of Sato et al. (1984), and rabbit anti-
rat PGST antiserum was prepared as described by Hendrich
and Pitot (1987).
The second frozen serial section was stained for GGT
activity as described by Rutenburg et al. (1968). The substrate
for GGT was ç-glutamyl-4-naphthylamide (GMNA) (United
States Biochemical Corp., Cleveland, OH).
Altered hepatic foci were quantified via computerized ste-
reology by slight modification of a program which was devel-
oped by Dr. Harold Campbell at McArdle Laboratories,
University of Wisconsin, Madison (Campbell et al., 1986). Two
magnified images of the serial sections stained for GGT activity
and PGST were projected onto a Summagraphics Microgrid
II digitizer screen and automatically plotted on an HP 9872C
plotter controlled by an HP9845B computer (Hewlett-Packard,
Palo Alto, CA) connected to an LA120 printer (Digital Equip-
ment Corp., Maynard, MA) to quantify AHF.
Radioimmunoassay for Endogenous Liver Prosta-
glandin F2r and E2 Levels. Endogenous liver PGF2R and
PGE2 levels were determined by radioimmunoassay according
to the method of McCosh et al. (1976). Anti-rat PGF2R rabbit
antiserum was purchased from Sigma. Anti-rat PGE2 rabbit
antiserum was a gift from Dr. Jaqueline Dupont, USDA-ARS,
Beltsville, MD. Goat anti-rabbit gamma globulin (ARGG) was
obtained fromWestern Chemical Research Corp., Fort Collins,
CO. Concentrated [3H]PGF2R and [3H]PGE2 with specific
activities of 168.0 and 154.0 Ci/mmol, respectively, were
purchased from Dupont New England Nuclear, Boston, MA.
Standards of PGF2a and PGE2 were obtained from Sigma.
Scintiverse BD (Fisher Chemical, Fair Lawn, NJ) was added
to each tube before counting. Sample-containing tubes were
run in duplicate. Total count tubes and background tubes
were counted in triplicate. Six replicates were made to
determine total binding. Along with the samples, a standard
curve was run in duplicate, one set at the beginning of the
sample run and the other set at the end. Radioactivity was
determined as cpm using a Packard liquid scintillation ana-
lyzer model 1900 TR (Packard Instrument Co., Downers Grove,
IL).
Natural Tumor Cytotoxicity Assay. In the experiment
with purified FB1, tumor cytotoxicity of liver NK cells was
assessed on the first seven animals sacrificed from each group
due to time constraints in performing the assay. The liver
perfusate containing Pitt cells was layered over 3 mL of
Accupaque (Accurate Chemical Co., Westbury, NY). The cells
were centrifuged for 15 min at 15 000 rpm in a swinging
bucket centrifuge (Model CR312, Jouan, Winchester, VA). The
cells at the interface of the density gradient media were
collected, washed twice with complete media (RPMI-1640
supplemented with 50 íg/mL gentamicin, 25 mM HEPES, 2
mM L-glutamine (all from Life Technologies, Gaithersburg,
MD) and 10% fetal bovine serum (FBS) (JRH Scientific,
Lenexa, KS)), and enumerated on a Celltrack II (NOVA
Biomedical, Waltham, MA). The cells from each sample were
diluted to 5  106 and plated in 96-well plates (Model 3595,
Costar, Cambridge, MA) to obtain 20, 10, 5, and 2.5  105 cells
(effectors)/well in triplicate. The targets for the assay were
YAC-1 cells, which had been labeled with 200 íCi of 51Cr (401
mCi/mg, Dupont New England Nuclear) for 70 min, and
maintained in complete media. The targets were washed three
times prior to dilution, and 104 targets were plated in each
well of the NK assay including control wells to determine
spontaneous and maximum release. The plates were incu-
bated for 4.5 h in a humidified CO2 incubator (5% CO2, 95%
air) (Fisher Scientific). At the end of the incubation the plate
was centrifuged at 500 rpm for 5 min, and 100 íL of
supernatant was collected to determine the amount of 51Cr
released by dying cells using a Gamma Trac 1191 (TM
Analytic, Inc., Elk Grove Village, IL). The cpm detected were
used to calculate the lytic units (LU) of activity at 20% lysis
in 107 effectors using a computer program.
Statistical Analysis. The liver PGF2R and PGE2 concen-
trations were determined by a computer program based on a
logit transformation of the standard curve (Duddleson et al.,
1972). One-way ANOVA was performed to analyze feed
consumption, body weight, plasma total cholesterol level and
ALT activity, endogenous hepatic PGF2a and PGE2 concentra-
tions, and natural tumor cytotoxicity, using the Statistical
Analysis System (Cary, NC). Student’s t-test was performed
to compare group differences after ANOVA. A P value of <0.05
was considered to be statistically significant. For the analysis
of computerized stereology of AHF, only the means and
standard deviations were given because the means equalled
zero in basal and FB1-fructose groups.
RESULTS
Experiment 1. Male Rats Fed Crude Fumonisin
B1. In comparison with the rats fed basal diet and the
rats fed FB1-fructose, the FB1-fed rats had significantly
increased plasma total cholesterol concentration and
ALT activity by 85% (P < 0.01) and 100% (P < 0.05),
respectively (Table 3).
The PGF2R concentration was significantly increased
by approximately 51% in the rats fed FB1 as compared
with those in the other groups (P < 0.05) (Table 3).
There were no significant differences in PGE2 levels
among the groups (Table 3).
All FB1-fed rats had both PGST- and GGT-positive
AHF. The average PGST-positive AHF area percentage
Table 3. Increased Plasma Total Cholesterol Concentration, Plasma Alanine Aminotransferase (ALT) Activity, and
Endogenous Hepatic Prostaglandin (PG) Production in Rats Fed Crude or Highly Purified Fumonisin B1 (FB1),
Compared with Feeding FB1 Reacted with Fructose (FB1-Fructose) or a Basal Diet
plasma cholesterol (mg/dL) plasma ALT activity (units/L) hepatic PGF2R (ng/g) hepatic PGE2 (ng/g)
Expt 1. Male Rats Fed Crude FB1
basal (n ) 6) 143 ( 24 58 ( 13 49 ( 8 4 ( 1
FB1 (n ) 7) 261 ( 45b 105 ( 58a 77 ( 22a 7 ( 2
FB1-fructose (n ) 7) 145 ( 33 51 ( 8 53 ( 13 5 ( 3
Expt 2. Female Rats Fed Highly Purified FB1
basal (n ) 15) 113 ( 28 45 ( 11 5 ( 2 2 ( 1
FB1 (n ) 12) 261 ( 68b 75 ( 22a 10 ( 4a 4 ( 2a
FB1-fructose (n ) 12) 121 ( 27 50 ( 11 5 ( 3 2 ( 1
a Significantly different from the basal group in respective study, P < 0.05. b Significantly different from the basal group in respective
study, P < 0.01.
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was 5.0 ( 6.3, and the average GGT-positive AHF area
percentage was 1 ( 1 in the rats fed FB1 at 69.3 ímol/
kg diet (Table 4). There were no detectable PGST- or
GGT-positive AHF in the group fed 69.3 ímol/kg FB1
reacted with fructose or in the control group (Table 4).
Experiment 2. Female Rats Fed Highly Purified
Fumonisin B1. The average daily feed intake in FB1
group, FB1-fructose group and basal group was 11 ( 1,
13 ( 2, and 13 ( 1 g, respectively. There were no sig-
nificant differences in the total feed intake or the aver-
age daily feed intake among the three groups (Table 2).
The rats in the FB1-treated group had significant
reductions in both body weight (by 12%, P < 0.05) and
body weight gain (by 16%, P < 0.05) as compared with
the rats in the groups fed FB1-fructose and basal diet
(Table 2).
In comparison with the basal group and the group fed
FB1-fructose, rats fed FB1 at 69.3 ímol/kg diet had
significantly increased plasma total cholesterol concen-
tration and ALT activity by about 2.3-fold (P < 0.01)
and 1.7-fold (P < 0.05), respectively (Table 3).
The PGF2R and PGE2 concentrations were both sig-
nificantly increased by 2-fold in rats fed 69.3 ímol/kg
FB1-containing diet as compared with those in the other
groups (P < 0.05) (Table 3).
All of the rats fed FB1 developed PGST- and GGT-
positive AHF. The average number of PGST-positive
AHF and the average PGST-positive AHF area percent-
age were 50 ( 17 and 68 ( 18, respectively, and the
average number of GGT-positive AHF and the average
GGT-positive AHF area percentage were 45 ( 13 and
61 ( 13, respectively, in the rats fed FB1 (Table 4).
There were no detectable PGST- or GGT-positive AHF
in either the group fed FB1-fructose or basal diet (Table
4).
Compared with the control rats, tumor cytotoxicity
was significantly suppressed in animals fed FB1 (P <
0.03) and significantly elevated in animals fed FB1-
fructose diet (P < 0.01) (Figure 1). Thus, feeding highly
purified FB1 or FB1-fructose induced significant and
opposing changes in liver tumor cytotoxicity.
DISCUSSION
These studies demonstrated that subjecting FB1 to
nonenzymatic browning conditions with fructose elimi-
nated FB1 toxicity as reflected in body weight, plasma
total cholesterol concentration, and ALT activity, de-
velopment of GGT- and PGST-positive AHF, and con-
centrations of endogenous hepatic PGF2R and PGE2.
Loss of amine group reactivity toward OPA was taken
as an indication that the amine had condensed with
fructose (Murphy et al., 1995). Results with either
crude or highly purified FB1 were generally similar,
showing detoxification of FB1, because in both cases FB1
reacted with fructose did not promote hepatocarcino-
genesis in rats and did not increase plasma cholesterol
concentration, plasma ALT activity, or hepatic PGF2R,
whereas feeding crude or highly purified FB1 signifi-
cantly increased all of these parameters compared with
rats fed a basal diet (Tables 3 and 4). The greater
development of PGST- and GGT-positive AHF, by 5- and
13-fold, respectively, caused by highly purified FB1
compared with crude FB1 (Table 4), may be due simply
to inherent variability of the two cohorts of rats in their
responsiveness to the carcinogenesis protocol used. Rats
are highly variable in individual response to such
protocols. Other signs of FB1 toxicity were quite similar
whether crude or purified FB1 was fed. This result may
suggest that females are more susceptible to promotion
of cancer by FB1 than the males, but no other studies
have examined this.
The chemical modification of FB1 by fructose by a
Maillard reaction probably caused the formation of a
Schiff’s base, FB1-fructose adduct, in which the FB1
amine group was combined with the fructose ketone.
The addition of the bulky fructose did not cause FB1 to
be less absorbed in the intestine even though this may
increase both water solubility and molecular size (Hop-
mans et al., submitted). At the molecular level, FB1
toxicity is most likely due to its inhibition of ceramide
synthase, a key enzyme in de novo sphingolipid biosyn-
thesis (Wang et al., 1991). Perhaps the presence of
fructose blocked the inhibitory binding of FB1 to cer-
amide synthase.
The putative effectiveness of the detoxification of FB1
by reaction with fructose suggested that the amine
group of FB1 was critical to FB1 toxicity. This was in
accordance with another study in which the N-acetyl
Table 4. Placental Glutathione S-Transferase (PGST)- and ç-Glutamyl Transferase (GGT)-Positive Altered Hepatic Foci
(AHF) Occurred Only in Rats Fed either Crude Fumonisin B1 (FB1) or Highly Purified FB1
no. of PGST lesions no. of GGT lesions % of PGST lesion area % of GGT lesion area
Expt 1. Male Rats Fed Crude FB1
basal (n ) 6) 0 0
FB1 (n ) 7) 5 ( 6 1 ( 1
FB1-fructose (n ) 7) 0 0
Expt 2. Female Rats Fed Highly Purified FB1
basal (n ) 15) 0 0 0 0
pure FB1 (n ) 12) 50 ( 17 45 ( 13 68 ( 18 61 ( 13
FB1-fructose (n ) 12) 0 0 0 0
Figure 1. Tumor cytotoxicity of liver-associated NK cells
against YAC-1 target cells, expressed as mean lytic units (LU)
( SE (n ) 7/group), in female rats fed fumonisin B1 (FB1),
FB1 reacted with fructose (FB1-fructose), or a basal diet.
Treatments marked by different letters were significantly
different from basal group: b, P < 0.03; C, P < 0.01.
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derivative of FB1 showed no hepatotoxicity and no
hepatocarcinogenicity (Gelderblom et al., 1993).
The significant reductions in body weight and body
weight gain of female rats fed FB1 compared with the
other groups were accompanied by normal feed consump-
tion (Table 2). This did not agree with another study
in which both body weight and feed intake in male
Sprague-Dawley rats were significantly decreased after
intraperitoneal injection of FB1 (Bondy et al., 1995).
Neither body weight nor feed intake was significantly
decreased after FB1 consumption by male and female
Fischer 344 rats (Voss et al., 1995). The difference
between our results and the others cannot be readily
explained.
Fumonisin B1-induced hypercholesterolemia as ob-
served in the present studies (Table 3) was reported in
vervet monkeys (Fincham et al., 1992), as well as in rats
fed FB1 (Hendrich et al., 1993). Hypercholesterolemia
is an observed effect of other tumor-promoting agents
and toxicants, such as phenobarbital (Katayama et al.,
1991). The hypercholesterolemic mechanism of FB1 is
unknown.
In agreement with the findings of Hendrich et al.
(1993), FB1 fed to rats at 69.3 ímol/kg diet for 4 weeks
increased not only plasma total cholesterol but plasma
ALT activity as well (Table 3). Elevated plasma ALT
activity indicated hepatocyte membrane damage which
led to the leakage of ALT into the blood. Such damage
was associated with the development of AHF caused by
FB1 (Hendrich et al., 1993).
Placental glutathione S-transferase-positive AHF and
GGT-positive AHF were found only in FB1-fed rats in
both studies (Table 4). Placental glutathione S-trans-
ferase and GGT are useful markers of FB1 hepatocar-
cinogenesis. The induction of PGST could be demon-
strated in single putatively initiated hepatocytes within
48 h after DEN treatment (Moore et al., 1987). Both
PGST and GGT persisted during hepatocarcinogenesis
(Hendrich and Pitot, 1987). In the present study,
placental glutathione S-transferase- and GGT-positive
AHF were detected after 4 weeks of FB1 treatment. This
indicated that both PGST and GGT were induced at an
early stage of hepatocarcinogenesis and could serve as
sensitive markers of FB1-induced hepatocarcinogenesis.
Because PGST- and GGT-positive AHF were virtually
undetectable in DEN-initiated rats fed FB1 reacted with
fructose, FB1 promotion of carcinogenesis may be blocked
by modifying FB1 with fructose.
Only FB1-treated rats showed significantly greater
amounts of endogenous PGF2R and PGE2 compared with
the control group, and PGST- and GGT-positive AHF
were only present in FB1-fed rats. The elevation of
hepatic PGF2R and PGE2 concentrations paralleled the
induction of AHF in the liver. Therefore, increased PG
production is related to promotion of rat hepatocarcino-
genesis caused by FB1. Both PGF2R and PGE2 may
contribute to cell proliferation in the liver during FB1
treatment. Prostaglandins of the F series stimulated
the proliferation of neonatal rat hepatocytes (Armato
and Andreis, 1983). Prostaglandins including PGF2R
and PGE2 also played a role in proliferation of hepatoma
cells (Trevisani et al., 1980). Direct evidence of stimu-
latory effect of PGs on the proliferation of hepatoma cells
was shown by the reversal of decreased hepatoma cell
numbers by PGE2 in indomethacin-treated rats (Tre-
visani et al., 1980).
Prostaglandins may also exert indirect effects on
proliferation of tumor cells by suppressing the local
immune response. Prostaglandins were able to make
macrophages and/or lymphocytes less sensitive to vari-
ous stimuli (Pelus and Strausser, 1977; Schultz et al.,
1978). Moreover, prostaglandin E2 suppressed NK cells
and lymphokine-activated killer (LAK) cells (Ohnishi et
al., 1991; Roth and Golub, 1993; Baxevanis et al., 1993).
The present studies showed that hepatic PGF2R and
PGE2 concentrations were significantly increased in
FB1-induced promotion of rat hepatocarcinogenesis
(Tables 3 and 4), and in the female rats fed purified FB1,
liver-associated antitumor response was decreased (Fig-
ure 1). However, the mechanism for enhancement of
tumor cytotoxicity in the FB1-fructose-fed group is not
clear as this group did not differ from the basal diet
group in any of the other measures. The tumor cytotoxic
cells of the liver are Pitt cells, which are similar to blood
NK cells, but with higher lytic activity. The possible
immune-enhancing effect of FB1-fructose deserves
further study.
The mechanism of FB1-induced carcinogenesis is still
not fully understood. Fumonisin B1 is an inhibitor of
sphingolipid synthesis (Wang et al., 1991). Sphingolip-
ids may be anticarcinogenic because they are down-
regulators of protein kinase C (Merrill, 1991), which
could affect many enzyme activities after it is activated
by carcinogens (Weinstein, 1987). It is not known
whether FB1 can stimulate phospholipase A2 which
hydrolyzes phospholipids to release the PG precursor,
arachidonate, or activate cyclooxygenase to produce
more PGs in the liver. Prostaglandin F2R was shown
to stimulate the formation of intracellular diacylglycerol
in Swiss 3T3 cells (Macphee et al., 1984), which can in
turn activate protein kinase C. Perhaps FB1-induced
alteration of sphingolipid metabolism stimulates PG
production, by an unknown mechanism.
Possibly decreased inhibitory binding of FB1 to cer-
amide synthase as a result of FB1 reaction with fructose
may be the mechanism of FB1 detoxification in this
experiment. Further study is needed to identify the
structure of the putative FB1-fructose conjugate and
investigate its stability, possible processing occurrence,
bioavailability and toxicity.
ABBREVIATIONS
Used FB1, fumonisin B1; DEN, diethylnitrosamine;
ALT, alanine aminotransferase; PG, prostaglandin;
PGST, placental glutathione S-transferase; GGT,
ç-glutamyl transferase; AHF, altered hepatic foci; NK
cell, natural killer cell; and OPA, o-phthaldialdehyde.
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